2'-beta-D-Arabinouridine

ID: ALA1092065

Cas Number: 3083-77-0

PubChem CID: 18323

Product Number: U101145, Order Now?

Max Phase: Preclinical

Molecular Formula: C9H12N2O6

Molecular Weight: 244.20

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Synonyms: Arauridine | Spongouridine|3083-77-0|Arauridine|1-beta-D-Arabinofuranosyluracil|ARABINOFURANOSYLURACIL|Uracil arabinoside|Ara-U|Uracil-beta-D-arabinofuranoside|1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione|Arabinosyluracil|Spongouridin|ZK0WMW5NQF|CHEBI:68346|MFCD00065998|Uridine arabinoside|Spongouridine (VAN)|1-beta-D-Arabinofuranosylpyrimidine-2,4(1H,3H)-dione (Uracil Arabinoside)|NSC 68928|1beta-D-Arabinofuranosyluracil|1-beta-D-ArabinofurnosShow More

Canonical SMILES:  O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]1

Standard InChI:  InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7+,8-/m1/s1

Standard InChI Key:  DRTQHJPVMGBUCF-CCXZUQQUSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
    6.7416  -16.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5666  -16.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8234  -15.3201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1541  -14.8333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4891  -15.3201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6092  -15.0661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3196  -15.4794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0345  -15.0749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0440  -14.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3323  -13.8304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6112  -14.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3146  -16.3044    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0508  -16.7722    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7044  -15.0655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2558  -16.7710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0915  -15.6178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7626  -13.8444    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  4  5  1  0
  5  1  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  1  2  1  0
  7 12  2  0
  3  6  1  1
  2 13  1  1
  6  7  1  0
  5 14  1  1
  1 15  1  6
  2  3  1  0
 14 16  1  0
  3  4  1  0
  9 17  2  0
M  END

Alternative Forms

Associated Targets(Human)

NB-4 (999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KG-1 (867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 2 (4932 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 2 (5592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Respiratory syncytial virus (3434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B4 (2249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mammalian orthoreovirus 1 (1523 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sindbis virus (1599 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Punta Toro virus (1491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human respirovirus 3 (1674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 244.20Molecular Weight (Monoisotopic): 244.0695AlogP: -2.85#Rotatable Bonds: 2
Polar Surface Area: 124.78Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: -2.42CX LogD: -2.42
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.44Np Likeness Score: 1.49

References

1. Mehellou Y, Valente R, Mottram H, Walsby E, Mills KI, Balzarini J, McGuigan C..  (2010)  Phosphoramidates of 2'-beta-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism.,  18  (7): [PMID:20299228] [10.1016/j.bmc.2010.02.059]
2. Yang JH, Kondratyuk TP, Jermihov KC, Marler LE, Qiu X, Choi Y, Cao H, Yu R, Sturdy M, Huang R, Liu Y, Wang LQ, Mesecar AD, van Breemen RB, Pezzuto JM, Fong HH, Chen YG, Zhang HJ..  (2011)  Bioactive compounds from the fern Lepisorus contortus.,  74  (2): [PMID:21261296] [10.1021/np100373f]
3. Torrence PF, Huang GF, Edwards MW, Bhooshan B, Descamps J, De Clercq E..  (1979)  5-Substituted uracil arabinonucleosides as potential antiviral agents.,  22  (3): [PMID:218014] [10.1021/jm00189a020]
4. Kulikowski T, Zawadzki Z, Shugar D, Descamps J, De Clercq E..  (1979)  Synthesis and antiviral activities of arabinofuranosyl-5-ethylpyrimidine nucleosides. Selective antiherpes activity of 1-(beta-D-arabinofuranosyl)-5-ethyluracil.,  22  (6): [PMID:222908] [10.1021/jm00192a008]
5. Schinazi RF, Chen MS, Prusoff WH..  (1979)  Antiviral and antineoplastic activities of pyrimidine arabinosyl nucleosides and their 5'-amino derivatives.,  22  (10): [PMID:229223] [10.1021/jm00196a025]
6. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]
7. Guinan M, Huang N, Smith M, Miller GJ..  (2022)  Design, chemical synthesis and antiviral evaluation of 2'-deoxy-2'-fluoro-2'-C-methyl-4'-thionucleosides.,  61  [PMID:35123007] [10.1016/j.bmcl.2022.128605]